本页面由Tiger Trade Technology Pte. Ltd.提供服务

德康医疗

71.25
+2.393.47%
盘后71.250.00000.00%19:52 EDT
成交量:329.93万
成交额:2.34亿
市值:274.22亿
市盈率:30.54
高:71.57
开:69.14
低:69.14
收:68.86
52周最高:89.98
52周最低:54.11
股本:3.85亿
流通股本:3.82亿
量比:0.69
换手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):2.33
每股收益(LYR):2.09
净资产收益率:35.62%
总资产收益率:9.65%
市净率:9.27
市盈率(LYR):34.10

数据加载中...

2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

重要事件披露

Form 8-K - Current report
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

重要事件披露

Form 8-K - Current report
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities